150 related articles for article (PubMed ID: 19524135)
1. Reducing betaglycan expression by RNA interference (RNAi) attenuates inhibin bioactivity in LbetaT2 gonadotropes.
Escalona RM; Stenvers KL; Farnworth PG; Findlay JK; Ooi GT
Mol Cell Endocrinol; 2009 Aug; 307(1-2):149-56. PubMed ID: 19524135
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
3. Gonadotrophins modulate hormone secretion and steady-state mRNA levels for activin receptors (type I, IIA, IIB) and inhibin co-receptor (betaglycan) in granulosa and theca cells from chicken prehierarchical and preovulatory follicles.
Lovell TM; Al-Musawi SL; Gladwell RT; Knight PG
Reproduction; 2007 Jun; 133(6):1159-68. PubMed ID: 17636170
[TBL] [Abstract][Full Text] [Related]
4. Endogenous betaglycan is essential for high-potency inhibin antagonism in gonadotropes.
Wiater E; Lewis KA; Donaldson C; Vaughan J; Bilezikjian L; Vale W
Mol Endocrinol; 2009 Jul; 23(7):1033-42. PubMed ID: 19372236
[TBL] [Abstract][Full Text] [Related]
5. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
6. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome.
Zhu R; Zhou X; Chen Y; Qiu C; Xu W; Shen Z
J Obstet Gynaecol Res; 2010 Feb; 36(1):138-46. PubMed ID: 20178540
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
[TBL] [Abstract][Full Text] [Related]
9. Messenger RNA and protein expression analysis of betaglycan in the pituitary and ovary of the domestic hen.
Sweeney SA; Johnson PA
Biol Reprod; 2005 Jan; 72(1):172-8. PubMed ID: 15385424
[TBL] [Abstract][Full Text] [Related]
10. Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin.
Chapman SC; Woodruff TK
Endocrinology; 2003 Dec; 144(12):5640-9. PubMed ID: 14500575
[TBL] [Abstract][Full Text] [Related]
11. Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo.
Makanji Y; Temple-Smith PD; Walton KL; Harrison CA; Robertson DM
Endocrinology; 2009 Oct; 150(10):4784-93. PubMed ID: 19589860
[TBL] [Abstract][Full Text] [Related]
12. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
Chapman SC; Bernard DJ; Jelen J; Woodruff TK
Mol Cell Endocrinol; 2002 Oct; 196(1-2):79-93. PubMed ID: 12385827
[TBL] [Abstract][Full Text] [Related]
13. Betaglycan (TGFBR3) Functions as an Inhibin A, but Not Inhibin B, Coreceptor in Pituitary Gonadotrope Cells in Mice.
Li Y; Fortin J; Ongaro L; Zhou X; Boehm U; Schneyer A; Bernard DJ; Lin HY
Endocrinology; 2018 Dec; 159(12):4077-4091. PubMed ID: 30364975
[TBL] [Abstract][Full Text] [Related]
14. Follistatin, induced by thyrotropin-releasing hormone (TRH), plays no role in prolactin expression but affects gonadotropin FSHbeta expression as a paracrine factor in pituitary somatolactotroph GH3 cells.
Oride A; Kanasaki H; Purwana IN; Mutiara S; Miyazaki K
Regul Pept; 2009 Aug; 156(1-3):65-71. PubMed ID: 19446581
[TBL] [Abstract][Full Text] [Related]
15. Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
Hempel N; How T; Dong M; Murphy SK; Fields TA; Blobe GC
Cancer Res; 2007 Jun; 67(11):5231-8. PubMed ID: 17522389
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of inhibin action.
Cook RW; Thompson TB; Jardetzky TS; Woodruff TK
Semin Reprod Med; 2004 Aug; 22(3):269-76. PubMed ID: 15319829
[TBL] [Abstract][Full Text] [Related]
17. Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan.
Makanji Y; Harrison CA; Stanton PG; Krishna R; Robertson DM
Endocrinology; 2007 May; 148(5):2309-16. PubMed ID: 17272393
[TBL] [Abstract][Full Text] [Related]
18. Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma.
Florio P; Ciarmela P; Reis FM; Toti P; Galleri L; Santopietro R; Tiso E; Tosi P; Petraglia F
Eur J Endocrinol; 2005 Feb; 152(2):277-84. PubMed ID: 15745937
[TBL] [Abstract][Full Text] [Related]
19. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients.
Muttukrishna S; Bearfield C; Johns J; Jauniaux E
Mol Hum Reprod; 2004 Nov; 10(11):793-8. PubMed ID: 15361555
[TBL] [Abstract][Full Text] [Related]
20. Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells.
Liu J; Kuulasmaa T; Kosma VM; Bützow R; Vänttinen T; Hydén-Granskog C; Voutilainen R
J Clin Endocrinol Metab; 2003 Oct; 88(10):5002-8. PubMed ID: 14557487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
